This chemical is primarily utilized in the field of medicinal chemistry and drug development, particularly as a potential therapeutic agent. It has been studied for its role as a selective antagonist or modulator of specific biological targets, such as ion channels or receptors, due to its unique structural properties. The trifluoromethyl groups enhance its binding affinity and metabolic stability, making it a promising candidate for targeting diseases related to neurological disorders or pain management. Additionally, its chiral structure allows for specific interactions with biological systems, enabling researchers to explore its efficacy in enantioselective applications. Its thiourea moiety further contributes to its ability to form hydrogen bonds, which is crucial for binding to protein targets. Ongoing research focuses on optimizing its pharmacokinetic and pharmacodynamic properties for potential clinical use.